Trulieve Cannabis Corp.
Trulieve Cannabis Corp. (TRUL.CN) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Trulieve Cannabis Corp. (TRUL.CN), featuring income statements, balance sheets, and cash flow data.
Trulieve Cannabis Corp. (TRUL.CN) Income Statement & Financial Overview
View the income breakdown for Trulieve Cannabis Corp. TRUL.CN across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $297.76M | $301.14M | $284.28M | $303.44M |
| Cost of Revenue | $114.54M | $114.13M | $111.006M | $121.79M |
| Gross Profit | $183.22M | $187.02M | $173.28M | $181.65M |
| Gross Profit Ratio | $0.62 | $0.62 | $0.61 | $0.60 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $118.77M | $157.94M | $148.62M | $102.58M |
| Operating Expenses | $149.89M | $185.71M | $172.66M | $130.66M |
| Total Costs & Expenses | $264.43M | $299.84M | $283.67M | $253.69M |
| Interest Income | $3.07M | $3.18M | $4.20M | $4.04M |
| Interest Expense | $16.30M | $14.62M | $17.46M | $15.45M |
| Depreciation & Amortization | $43.18M | $45.29M | $44.62M | $44.16M |
| EBITDA | $79.81M | $47.002M | $49.24M | $96.11M |
| EBITDA Ratio | $0.27 | $0.16 | $0.17 | $0.32 |
| Operating Income | $33.33M | $1.31M | $618000.00 | $49.75M |
| Operating Income Ratio | $0.11 | $0.004 | $0.002 | $0.16 |
| Other Income/Expenses (Net) | -$13.00M | -$14.21M | -$13.46M | -$13.25M |
| Income Before Tax | $20.33M | -$12.90M | -$12.84M | $36.51M |
| Income Before Tax Ratio | $0.07 | -$0.04 | -$0.05 | $0.12 |
| Income Tax Expense | $52.46M | $47.57M | $47.38M | $47.20M |
| Net Income | -$32.87M | -$59.78M | -$60.21M | -$12.03M |
| Net Income Ratio | -$0.11 | -$0.20 | -$0.21 | -$0.04 |
| EPS | -$0.12 | -$0.29 | -$0.32 | -$0.05 |
| Diluted EPS | -$0.12 | -$0.29 | -$0.32 | -$0.05 |
| Weighted Avg Shares Outstanding | $191.13M | $190.19M | $190.19M | $219.93M |
| Weighted Avg Shares Outstanding (Diluted) | $191.13M | $190.19M | $190.19M | $190.33M |
Over the past four quarters, Trulieve Cannabis Corp. demonstrated steady revenue growth, increasing from $303.44M in Q2 2024 to $297.76M in Q1 2025. Operating income reached $33.33M in Q1 2025, maintaining a consistent 11% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $79.81M, reflecting operational efficiency. Net income rose to -$32.87M, with EPS at -$0.12. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan